Taking a Look at the Data Behind Idera Pharmaceuticals, Inc. (IDRA)

Idera Pharmaceuticals, Inc. (IDRA) is an interesting player in the Healthcare space, with a focus on Biotechnology. The stock has been active on the tape, currently trading at $2.11, down from yesterday’s close by -0.94%. Given the stock’s recent action, it seemed like a good time to take a closer look at the company’s recent data.

Fundamental Analysis

Idera Pharmaceuticals, Inc. (IDRA) currently trades with a market capitalization of $415.10 Million. That value represents a market adjusting for revenues that have been falling by -49.23 % on a quarterly year/year basis as of the company’s last quarterly report.

You can get a sense of how sustainable that is by a levered free cash flow of -$39.15 Million over the past twelve months. Generally speaking, earnings are expected to hold steady in coming quarters. Analysts are forecasting earnings of -$0.09 on a per share basis this quarter. Perhaps, that suggests something about why 1.23% of the outstanding share supply is held by institutional investors.

Technical Analysis

We’ve taken a serious look at this stock from a fundamental perspective, but the tale of the tape may offer more hints about what lies under the surface. Looking at the stock’s movement on the chart, Idera Pharmaceuticals, Inc. recorded a 52-week high of $2.87. It is now trading 0.76% off that level. The stock is trading $2.00 its 50-day moving average by -0.11%. The stock carved out a 52-week low down at $1.30.

In recent action, Idera Pharmaceuticals, Inc. (IDRA) has made a move of -4.52% over the past month, which has come on Strong relative transaction volume. Over the trailing year, the stock is underperforming the S&P 500 by 19.03, and it’s gotten there by action that has been more volatile on a day-to-day basis than most other stocks on the exchange. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 2.19% with $165.74 Million sitting short, betting on future declines. That suggests something of the likelihood of a short squeeze in shares of IDRA.

Previous articleJust the Facts on Bank of America Corporation (BAC)
Next articleDigging Up the Facts on Verizon Communications Inc. (VZ)